Leif Eriksson

Medicin och livsvetenskap

1. Lung Transplantation 100%
2. Lung 88%
3. Bronchiolitis Obliterans 55%
4. Cystic Fibrosis 36%
5. Fibroblasts 27%
6. Extracellular Matrix 25%
7. Idiopathic Pulmonary Fibrosis 24%
8. Induced Hypothermia 24%
9. Tissue Donors 23%
10. Mesenchymal Stem Cells 18%
11. Chronic Obstructive Pulmonary Disease 18%
12. Transplantation 16%
13. Proteoglycans 16%
14. Bronchiolitis 15%
15. bactericidal permeability increasing protein 14%
16. Prolyl Hydroxylases 13%
17. Mastocytosis 13%
18. Respiratory Insufficiency 12%
19. Laser Capture Microdissection 12%
20. Antineutrophil Cytoplasmic Antibodies 11%
21. Versicans 11%
22. Vascular Endothelial Growth Factor Receptor-2 11%
23. Vascular Resistance 11%
24. rho-Associated Kinases 11%
25. Heparitin Sulfate 11%
26. X Ray Computed Tomography 11%
27. Vascular Remodeling 11%
28. Glucagon-Like Peptide 1 10%
29. Pseudomonas 10%
30. Bronchoscopy 10%
31. Glycosaminoglycans 9%
32. Wound Healing 9%
33. Mechanics 9%
34. Transplants 9%
35. Heart Ventricles 9%
36. Bone Marrow 8%
37. Phenotype 8%
38. perlecan 8%
39. Protein Kinases 8%
40. Autoantibodies 8%
41. Mast Cells 8%
42. Vascular Endothelial Growth Factor A 8%
43. Hypothermia 7%
44. Transforming Growth Factors 7%
45. Lung Diseases 7%
46. Diabetes Mellitus 7%
47. Biglycan 6%
48. Proteins 6%
49. Clinical Studies 6%
50. Decorin 6%